TrialJournal of gastroenterology2020

JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.

Tetsuo Takehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.